Roberto Delpini
Papers
1
Total Citations
14
H-Index
1
About
Roberto Delpini is a leading surgical oncologist whose research focuses on optimizing treatment protocols for rectal cancer, particularly the timing of minimally-invasive surgery following neoadjuvant chemoradiotherapy. His most notable contribution is the TiMiSNAR trial, a multicenter randomized controlled study that compared standard 8-week versus prolonged 12-week intervals to surgery after chemoradiation. This work addresses a critical controversy in colorectal oncology—whether extended waiting periods allow for more complete tumor regression before surgical intervention. With 14 citations, this landmark study has shaped clinical decision-making by providing high-quality evidence on surgical timing. Delpini’s research bridges the gap between retrospective observations of slow tumor regression and prospective validation, offering actionable insights for improving patient outcomes. His work demonstrates a commitment to rigorous trial design and translational impact, making him a key figure in advancing personalized surgical strategies for rectal cancer.
Research Focus
Key Achievements
Top Papers
- 1